logo mainlogo darklogo main
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
logo main logo darklogo light
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx
May 3, 2022

Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit

Accumulating evidence proves that endothelial dysfunction is involved in coronavirus disease 2019 (COVID-19) progression.

Read More
Microvascular dysfunction in COVID-19
October 14, 2021

Microvascular Dysfunction in COVID-19 Patients: MYSTIC Study

Research reveals that COVID-19 patients have severe damage to microcirculation and the endothelial glycocalyx. The data in a newly released study clearly show severe reduction of m

Read More
BioRegenx
About BioRegenx
  • Profile
  • People
  • Portfolio
  • Press
  • Contact Us
Get in touch

PO Box 21210
Chattanooga TN, 37424

(800) 398 - 9842

support@bioregenx.com

Headquarters in Chattanooga, TN
Additional Offices in Alpine, UT

Copyright © 2023 BioRegenx, Inc. All rights reserved

7407 Ziegler Rd Chattanooga, TN 37421

(800) 398 - 9842

support@bioregenx.com